Publication: Impact of levothyroxine therapy on lipid profile in overt hypothyroidism: a retrospective cohort study
Loading...
Files
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
AME Publishing Company
DOI
10.21037/aot-2025-1-19
Abstract
Background: Hypothyroidism is closely associated with dyslipidemia, contributing to cardiovascular morbidity and mortality. The aim of the current study was to assess levothyroxine impact on lipid profile parameters [total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C)], in subjects with overt hypothyroidism (OH) and hyperlipidemia and to determine whether the impact varies by levothyroxine dosage. Methods: A total of 111 adult subjects (25–60 years; mean age 43.5±8.3 years; 93.7% female) reporting to the primary health care centers of Dubai Health, United Arab Emirates between January 1st, 2020, and September 30th, 2020, with OH and hyperlipidemia were included in this study and data were analyzed using standard statistical methods. Participants were stratified into two groups based on levothyroxine dosage: <100 or ≥100 mcg. Lipid profile parameters were measured before and after treatment. Results: Levothyroxine doses ≥100 mcg significantly increased the percentage of controlled TC (40% increase, P<0.001), TG (20% increase, P<0.001), and LDL-C (35% increase, P<0.001) while doses of <100 mcg resulted in significant improvement in TC only (25.8% increase, P=0.008). Conclusions: Levothyroxine therapy resulted in a dose-dependent lipid control in OH subjects with hyperlipidemia. Higher doses were associated with more substantial lipid control. Future randomized controlled trials are warranted to confirm and generalize these findings.
